Is type 2 diabetes really a coronary heart disease risk equivalent?

Vascular Pharmacology

Volumn 59, Issue 1-2, 2013, Pages 11-18

  Saely, Christoph H ^a,b,c   Drexel, Heinz ^a,b,c,d  

^a Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^b Academic Teaching Hospital Feldkirch   (Austria)

^c PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Coronary artery disease; Coronary heart disease; Coronary heart disease risk equivalent; Diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ASYMPTOMATIC DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; DYSLIPIDEMIA; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SCREENING; SEX DIFFERENCE; SYSTEMATIC REVIEW (TOPIC);

EID: 84880698302     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.05.003     Document Type: Review

References (45)

1. Anon. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
2. Anon. Standards of medical care in diabetes-2013. Diabetes Care 2013, 36(Suppl. 1):S11-S66.
3. Baigent C., Blackwell L., Collins R., et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009, 373:1849-1860.
4. Becker A., Bos G., de Vegt F., et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur. Heart J. 2003, 24:1406-1413.
5. Belch J., MacCuish A., Campbell I., et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008, 337:a1840.
6. Booth G.L., Kapral M.K., Fung K., Tu J.V. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006, 368:29-36.
7. Bulugahapitiya U., Siyambalapitiya S., Sithole J., Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet. Med. 2009, 26:142-148.
8. Buyken A.E., von Eckardstein A., Schulte H., Cullen P., Assmann G. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. Eur. J. Cardiovasc. Prev. Rehabil. 2007, 14:230-236.
9. Carnethon M.R., Biggs M.L., Barzilay J., et al. Diabetes and coronary heart disease as risk factors for mortality in older adults. Am. J. Med. 2010, 123:556e1-556e9.
10. Centers for Disease Control and Prevention National Diabetes Fact Sheet Available at, (Last accessed 04 Feb 2013). http://www.cdc.gov/diabetes/pubs/estimates07.htm#7.
11. Cho E., Rimm E.B., Stampfer M.J., Willett W.C., Hu F.B. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J. Am. Coll. Cardiol. 2002, 40:954-960.
12. Eberly L.E., Cohen J.D., Prineas R., Yang L. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care 2003, 26:848-854.
13. Evans J.M., Wang J., Morris A.D. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002, 324:939-942.
14. Franco O.H., Steyerberg E.W., Hu F.B., Mackenbach J., Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch. Intern. Med. 2007, 167:1145-1151.
15. Gowdak L.H., de Paula F.J., Cesar L.A., et al. Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates. Nephrol. Dial. Transplant. 2007, 22:1456-1461.
16. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004, 110:227-239.
17. Hadaegh F., Fahimfar N., Khalili D., Sheikholeslami F., Azizi F. New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6year follow up in a Middle East population. Cardiovasc. Diabetol. 2010, 9:84.
18. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998, 339:229-234.
19. Ho J.E., Paultre F., Mosca L. Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project. Stroke 2003, 34:2812-2816.
20. Howard B.V., Best L.G., Galloway J.M., et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006, 29:391-397.
21. Hu F.B., Stampfer M.J., Solomon C.G., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20years of follow-up. Arch. Intern. Med. 2001, 161:1717-1723.
22. Hu G., Jousilahti P., Qiao Q., Katoh S., Tuomilehto J. Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction. Diabetologia 2005, 48:856-861.
23. Juutilainen A., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005, 28:2901-2907.
24. Kearney P.M., Blackwell L., Collins R., et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008, 371:117-125.
25. Lee C.D., Folsom A.R., Pankow J.S., Brancati F.L. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004, 109:855-860.
26. Lee C., Joseph L., Colosimo A., Dasgupta K. Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. Diabetes Metab. 2012, 38:420-427.
27. Lotufo P.A., Gaziano J.M., Chae C.U., et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch. Intern. Med. 2001, 161:242-247.
28. Malmberg K., Yusuf S., Gerstein H.C., et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000, 102:1014-1019.
29. Mihaylova B., Emberson J., Blackwell L., et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012, 380:581-590.
30. Mukamal K.J., Nesto R.W., Cohen M.C., et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001, 24:1422-1427.
31. Natarajan S., Liao Y., Cao G., Lipsitz S.R., McGee D.L. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch. Intern. Med. 2003, 163:1735-1740.
32. Natarajan S., Liao Y., Sinha D., Cao G., McGee D.L., Lipsitz S.R. Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch. Intern. Med. 2005, 165:430-435.
33. Nathan D.M., Meigs J., Singer D.E. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it?. Lancet 1997, 350(Suppl. 1):SI4-SI9.
34. Norhammar A., Schenck-Gustafsson K. Type 2 diabetes and cardiovascular disease in women. Diabetologia 2013, 56:1-9.
35. Ogawa H., Nakayama M., Morimoto T., et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 2008, 300:2134-2141.
36. Pajunen P., Koukkunen H., Ketonen M., et al. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia 2005, 48:2519-2524.
37. Rashidi A., Sehgal A.R., Rahman M., O'Connor A.S. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65years. Am. J. Cardiol. 2008, 102:1668-1673.
38. Reiner Z., Catapano A.L., De Backer G., et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur. Heart J. 2011, 32:1769-1818.
39. Saely C.H., Aczel S., Marte T., Langer P., Drexel H. Cardiovascular complications in type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state. Diabetologia 2004, 47:145-146.
40. Saely C.H., Aczel S., Koch L., et al. Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?. Eur. J. Cardiovasc. Prev. Rehabil. 2010, 17:94-99.
41. Saely C.H., Rein P., Vonbank A., Huber K., Drexel H. Type 2 diabetes and the progression of visualized atherosclerosis to clinical cardiovascular events. Int. J. Cardiol. 2012, [in press, Electronic publication ahead of print].
42. Simons L.A., Simons J. Diabetes and coronary heart disease. N. Engl. J. Med. 1998, 339:1714-1715. (author reply 6).
43. Vaccaro O., Eberly L.E., Neaton J.D., Yang L., Riccardi G., Stamler J. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch. Intern. Med. 2004, 164:1438-1443.
44. Wannamethee S.G., Shaper A.G., Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart 2004, 90:1398-1403.
45. Whiteley L., Padmanabhan S., Hole D., Isles C. Should diabetes be considered a coronary heart disease risk equivalent?: results from 25years of follow-up in the Renfrew and Paisley survey. Diabetes Care 2005, 28:1588-1593.